1st Qatar Molecular Imaging and 9th Gulf Nuclear Medicine Conference
Objectives:
The joint conference is an opportunity for molecular imaging & nuclear medicine professionals:
- To update the knowledge on the recent developments in this specialty.
- To be aware of new techniques and applications in the diagnosis and therapy using radiopharmaceuticals.
- To refresh knowledge in quality control, quality assurance, and radiation safety.
- To develop contacts and establish collaboration in the clinical, academic, and research areas.
Overview:
We are inviting 10 international and regional experts to present their experience. Nine clinical sessions are planned where 3-4 lectures will be delivered. The first session will be dedicated to welcoming the delegates and inauguration. Two sessions each for PET/CT, General Nuclear Medicine, Cardiology, and Theragnostic are scheduled. In addition to FDG PET/CT, conventional nuclear medicine, I-131 therapy, and SPECT/CT, the lectures/presentations by the experts will also cover the PEM, non-FDG PET/CT, PET/MRI, imaging in cardiac amyloidosis, AI, new therapy tracers and conventional Nuclear Medicine in endocrine, renal, bone and GI disorders will also be covered by experts.
There will be four parallel sessions on techniques, radiation safety, image processing, and reconstruction of hybrid imaging primarily for the scientists and technical staff working in nuclear medicine.
Programs:
Registration fee:
| Attendee | In-Person | Virtual |
| Physician/ Scientist | 300 QAR | 100 QAR |
| Residents/Fellows | 150 QAR | 50 QAR |
| Technologist | 150 QAR | 50 QAR |
| Nurses | 100 QAR | 50 QAR |
Organizer
Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. HMC is leading the development of the region’s first academic health system – combining innovative research, top-class education and excellent clinical care – and is committed to building a legacy of healthcare expertise in Qatar. HMC collaborates with key partners who are experts in Qatar and beyond, including Weill Cornell Medicine-Qatar, the Institute for Healthcare Improvement and Partners Healthcare, Boston.
